<DOC>
	<DOCNO>NCT00183989</DOCNO>
	<brief_summary>This study do order determine effectiveness combination fludarabine , mitoxantrone , rituximab patient mantle cell lymphoma . All three drug , fludarabine , mitoxantrone , rituximab approve U.S. Food Drug Administration ( FDA ) treatment certain type lymphoma . Rituximab drug ( call monoclonal antibody ) anti-tumor activity certain type lymphoma . The combination chemotherapy ( fludarabine mitoxantrone ) rituximab yet investigate patient mantle cell lymphoma therefore combination investigational .</brief_summary>
	<brief_title>Combination Therapy With Fludarabine , Mitoxantrone Rituximab Mantle Cell Lymphoma</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Mantle-Cell</mesh_term>
	<mesh_term>Fludarabine</mesh_term>
	<mesh_term>Fludarabine phosphate</mesh_term>
	<mesh_term>Rituximab</mesh_term>
	<mesh_term>Mitoxantrone</mesh_term>
	<mesh_term>Vidarabine</mesh_term>
	<criteria>Pathologic diagnosis NonHodgkin 's Lymphoma mantle cell subtype lymphoma , determine morphologic assessment consistent immunophemotypic marker Newly diagnose patient receive prior treatment eligible Measurable evaluable disease Karnofsky performance status great equal 50 % Men woman , age great equal 18 year old AGC great equal 1.0 ; platelet great equal 75,000 ; Hemoglobin great equal 8.0 ( unless lymphomatous infiltration marrow ) Creatinine le 2.0 ; bilirubin le 2.0 ; SGOT le 3 time upper limit normal ( unless elevation due lymphomatous involvement ) Women child bear potential must negative pregnancy test within 14 day study entry . Signed informed consent History congestive heart failure significant cardiac disease Prior exposure either fludarabine mitoxantrone . Prior exposure rituximab allow Active infection HIV seropositive Pregnant lactating female Second active malignancy , squamous cell skin cancer , insitu cervical cancer , history cancer diagnose within precede 5 year Presence psychological emotional disorder would make valid inform consent impossible</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>